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Background: For residents of long term care, hospitalisations can cause distress and disruption, and often result in
further medical complications. Multi-disciplinary team interventions have been shown to improve the health of
Residential Aged Care (RAC) residents, decreasing the need for acute hospitalisation, yet there are few randomised
controlled trials of these complex interventions. This paper describes a randomised controlled trial of a structured
multi-disciplinary team and gerontology nurse specialist (GNS) intervention aiming to reduce residents’ avoidable
hospitalisations.
Methods/Design: This Aged Residential Care Healthcare Utilisation Study (ARCHUS) is a cluster- randomised
controlled trial (n = 1700 residents) of a complex multi-disciplinary team intervention in long-term care facilities.
Eligible facilities certified for residential care were selected from those identified as at moderate or higher risk of
resident potentially avoidable hospitalisations by statistical modelling. The facilities were all located in the Auckland
region, New Zealand and were stratified by District Health Board (DHB).
Intervention: The intervention provided a structured GNS intervention including a baseline facility needs
assessment, quality indicator benchmarking, a staff education programme and care coordination. Alongside this,
three multi-disciplinary team (MDT) meetings were held involving a geriatrician, facility GP, pharmacist, GNS and
senior nursing staff.
Outcomes: Hospitalisations are recorded from routinely-collected acute admissions during the 9-month
intervention period followed by a 5-month follow-up period. ICD diagnosis codes are used in a pre-specified
definition of potentially reducible admissions.
Discussion: This randomised-controlled trial will evaluate a complex intervention to increase early identification
and intervention to improve the health of residents of long term care. The results of this trial are expected in early
2013.
Trial registration: Australian New Zealand Clinical Trials Registry: ACTRN 12611000187943* Correspondence: sue.foster@waitematadhb.govt.nz
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Older people’s health is increasingly important for New
Zealand. Mid-range projections from Statistics New Zea-
land show the proportion of the population aged 75+
will increase from 5.6% in 2006, to 10.4% by 2031 and
14.7% by 2051. Similar ageing demographics exist
throughout the OECD, though New Zealand is still
‘young’ in comparison to most OECD nations. Those
over 85 years of age comprised 1.3% of the population in
2001, but used half of residential aged care (RAC) costs
[1]. New Zealand has high rates of use of residential
aged care ([2], in press) with about 70% of residents re-
ceiving public funds for their care (Grant Thornton
2010). Healthcare spending will increase markedly with
the rise of these ‘oldest old’.
In 2008 a census of older people in residential care
was completed in the Auckland region in New Zealand.
The findings revealed that 28% of those aged 85+ reside
in RAC facilities, and residents were increasingly older
and more dependent than previous surveys (2003, 1995,
1989) [3,4]. The need for residential care does not ap-
pear to have diminished even though a number of initia-
tives including Ageing-in-Place have been implemented
[5]. Those living in residential care facilities are at
increased risk of hospitalisation because their physical
and mental frailty increases their susceptibility to acute
illness and injuries [6]. Improvements in quality indica-
tors such as urinary tract infections, wounds, and falls
are associated with better resident health and decreased
hospitalisations [7,8]. Quality of care depends on the
staff, the facility and services available (Schnelle 2004).
Residential aged care needs to be ‘better managed’ to im-
prove quality [9] and reduce costs. ARC staff turnover is
high and increasing, with high vacancy rates, particularly
for registered nurses and caregivers [10]. There is a need
to develop new ways to support the RAC industry that
improve resident outcomes, which in turn possibly re-
duce avoidable hospitalisations.
Flicker [9] made recommendations for improving RAC
care: an interdisciplinary team approach, and partnering
with tertiary institutions and expert groups to develop
clinical guidelines to promote best practice. Several resi-
dent and facility interventions have been proven to improve
health care outcomes [11]. These include interdisciplinary
team medication reviews [12], nutritional screening
and intervention [13], facilitated end of life advanced
care planning [14] and outreach education and clin-
ical coaching [15].
Ambulatory sensitive hospitalisations (ASH) are those
that are potentially avoidable through early primary care
intervention, and include diagnoses such as syncope,
congestive heart failure (CHF), constipation, dehydration
and volume depletion, fall and hip fracture, influenza,
pneumonia and urinary tract infection (UTI) [16]. In aNew Zealand review of interventions specifically to re-
duce Ambulatory Sensitive Hospitalisations in younger
people [16] reported evidence for successful strategies
including: inter-disciplinary, collaborative and patient-
centred team approaches, education-based comprehen-
sive care programmes, outreach collaborations by both
specialists and generalists for disease-specific interven-
tions and increased access to services for all including
the under-served. However residential aged care was not
the focus for this review and most reported trials were
single-disease based. There is a large gap in the know-
ledge related to residential aged care transfers to acute
hospitals and how best to reduce them. There is a need
for detailed examination of available data to better
understand why hospitalisations occur in New Zealand
settings, in order to intervene rationally.
Evidence supports new models of care in RAC result
in reduced hospitalisations. Large scale organisations
such as Evercare, a large RCT of Nurse Practitioner in-
put into RAC in the United States, reduced acute hospi-
talisations [17] and similar results were reported from
Canada [18]. However the scope of these large scale
model changes is often beyond local funding capacity
and advanced nursing capability. In addition these stud-
ies and their subsequent clinical applications have pro-
vided only limited understanding of the types of
admissions impacted. It is clear that some admissions
are needed for acute and specialist care; however evi-
dence suggests that better preventive care and emphasis
on managing acute illness in situ improves resident
health outcomes. [19,20]. Structured RAC interventions
have demonstrated success in functional outcomes [21]
and falls [22], but apart from large scale model change,
actual reductions in hospitalisations are not yet proven.
Methods/design
This is a randomised controlled trial of a complex inter-
vention of a package of supports and services provided
by District Health Boards (DHBs) interdisciplinary team
outreach to RAC facilities.
The study is taking place in the greater Auckland area
of New Zealand. Auckland is the largest metropolitan
area of New Zealand with a population of 1.4 million
people. Within this region there are 175 aged care facil-
ities, from which the participating facilities were selected
on the basis of higher than ‘expected’ hospital admission
rates. A total sample size of 1400 resident-years was ori-
ginally anticipated to provide 80% power (5% signifi-
cance) to detect a 25% reduction in rate of ASH
hospitalisations in the intervention group compared to
the control group when an event rate of 60 events per
100 years was expected. However, observed event rate in
another cohort after commencement of the trial showed
a lower event rate, so power estimates were recalculated.
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follow-up, an average of 38 beds per facility and bed oc-
cupancy of 90%, we expect a total of 1500 resident
years of follow-up. Revised power is estimated at 53%,
considering:
 Inflated sample size as the design effect of 2.0 will
allow for moderate intracluster correlation for
hospitalisation rates of 0.025 [23,24]
 Rate of 35 ASH admissions per 100 resident years in
control facilities vs. 26 ASH admissions in
intervention facilities, assuming a Poisson
distribution where the mean equals the variance.
The control event rate was estimated from re-
analysis of the RACIP study (Boyd et al., 2008) and
the OPAL study cohort (results not yet published).
However, we anticipate an improvement in power
because;
 the facilities were chosen (from statistical modelling)
for their higher event rates (e.g. an event rate of 0.40
would provide power of 0.67)
 short-stay residents (under-represented in OPAL-
based rates) have a higher event rate
 adjustment for covariates in our analysis will reduce
confidence intervals around effect size
Facility selection
Eligible facilities were all those certified by the DHBs as
providing long-term care in the region. Details were
obtained of bed numbers and care level provided. Prior
to facility recruitment, we examined structural aspects
of RAC and evaluated potential associations with avoid-
able hospitalisations, known as ambulatory sensitive hos-
pitalisations (ASH), taking into account individuals’
demographics and health status. Routine reporting of
ASH events in New Zealand ceases at age 75, partly be-
cause established classifications of ASH diagnoses are
perceived to be ‘less relevant’ for older people, particu-
larly those in RAC. We thus developed an ASH classifi-
cation based on diagnoses that were relevant for the
RAC population. This classification method was used to
identify facilities with high hospitalisation rates using
multivariate modelling techniques that will be reported
separately. Facilities were selected from those identified
as at moderate or greater risk of resident hospitalisation
based on factors identified during modelling.
Facility recruitment
Initially facilities were contacted by phone by the project
manager and invited to participate in the study. This
was followed by a visit to confirm written informed con-
sent and to obtain base-line facility data after which thefacility was advised whether allocated to intervention or
control. In all, a total of 50 facilities were contacted and
invited to participate. Twelve facilities declined to take
part, citing work load and the similarity to another study
recently undertaken as the main reasons. Two facilities
withdrew shortly after randomisation because they did
not desire to continue with the research project. These
facilities were replaced with two other facilities as the
intervention had not begun. One control facility has
withdrawn half way through the study as it had changed
ownership and the new owners did not want to continue
participation in the research. Overall there has been an
very positive response to the study as most of the facil-
ities are keen to receive the perceived benefits of the
intervention (Figure 1).
Randomisation
Thirty-six facilities from three Auckland DHBs were
randomised following consent. Facility randomisation
was conducted by random number allocation, stratified
by DHB and mix of care types (rest home only, or a mix
of rest home, dementia and hospital beds). Facility iden-
tification was blinded to the main investigators wherever
possible (some of the researchers were involved in clin-
ical aspects of the intervention so were required to know
only those facilities to which they provided clinical in-
put). The control group were offered the same interven-
tions following the completion of the intervention stage
of the study. Control facilities were all blinded to all
investigators.
Ethical considerations
Full ethics approval was given by the Northern Y Ethics
Committee in January 2011 (NTY 10/11/090). Consent
was obtained for facility participation rather than indi-
vidual resident participation, as no identifying data is
being collected and none of the interventions will be
outside the usual clinical practice provided by facility
staff. Only National Health Index (NHI) numbers (a na-
tional healthcare identification number for each person
in New Zealand) were collected by the researchers. All
individual residents’ information was kept anonymous to
the researchers.
Intervention
The intervention builds on aged care programmes
already in place in the three Auckland region DHBs.
Each DHB has gerontology clinical nurse specialists
(GNSs) providing outreach to facilities, but the models
of care vary between the DHBs and there is no consist-
ent method to Identify high-risk facilities. The trial inter-
vention delivers outreach tailored to facility needs. The
multi-disciplinary team is considered a critical element
[25]. These teams were established at each of the three
Recruitment, Consent and Randomisation
• Initial contact by telephone
• Project manager completes consent visit and collects facility base-line data
• Facility randomly allocated to 2011 or 2012 start.  Randomised pair matched on site, heal
region and type of facility.  Blinded to investigators and others unless real need to know
• Facilities and GNSs (intervention facilities only) advised of allocation.
Identified facilities contacted (from modelling)
55 selected, top 10 in each DHB first
36 facilities randomised–stratified byDHB 
Matched by size and facility type
1 ceased operation
4 not required
1 withdrew after start
13 declined
Active Facilities = 18 Control Facilities = 18
Intervention for 9 months 
from March 2011-August 2012
Usual care from facility staff and
from DHB staff
Project manager obtained 
written consent and baseline 
data
Data collection from
randomisation to 14 months 
from matched pair’s start date
(monthly individual and facility 
level data collection)
• MDT intervention– 
monthly 
data collection
• GNS intervention–monthly 
data collection
• Project Manager–monthly 
facility and individual level 
data collection
Trial outcome follow-up 
complete July 2012
Intervention offered to control
group over 7 months August
2012-September 2013
Data collection continues for
14 months from start date
Follow-up complete July 2012
Figure 1 Process for recruitment and randomisation of facilities.
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vices. The team comprises the facility General Medical
Practitioner and Nurse Manager, a DHB geriatrician, a
DHB Gerontology Nurse Specialist and a community
pharmacist that services the facility or DHB clinical
pharmacist.
The interventions in this study include:
 Initial baseline facility assessment to identify areas of
need and facility care plan
 Benchmarking monitoring resident quality indicators
that are linked to the quality of care provided (falls,
nutrition, use of restraints, weight loss, UTIs,
residents on nine or more medications). Three one-hour multi-disciplinary team (MDT)
meetings to be held monthly for the first three
months at each intervention facility, including
medication reviews by the geriatrician in
conjunction with the GP, pharmacist and nurse
manager. At most, six residents were considered at
each meeting with new admissions, those recently
hospitalised, and those residents on nine or more
medications given priority.
 Gerontology education and clinical coaching for
RAC nurses and caregivers including advanced care
planning for end-of-life care, nutrition and
hydration, early identification of illness, falls
prevention, end-stage dementia care,
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concerned with resident care.
The intervention continued for nine months with the
intensity of the intervention decreasing over time to fos-
ter facility independence prior to the conclusion of ac-
tive involvement, including months 6 and 8 where
facilities did not receive any input by the GNSs. The
GNSs began the intervention with one new facility per
month in order to allow sufficient time for the organisa-
tion and delivery of the intervention.
Facilities provided monthly lists of all residents showing
only residents’ unique identifiers, care type, and admis-
sion and discharge dates, to facilitate tracking residents
and for sub-group analyses. The data for all acute hospi-
talisations and deaths will be retrieved from the Ministry
of Health’s routinely collected public hospital admissions
data on presentation of the unique identifier.
Outcome measures
The primary outcome measurements comprise:
1. Rate of ASH admissions classified using a pre-
determined set of ICD codes.
2. Number of acute admission hospital days.
3. Number of deaths from any cause, including death in
acute hospital or elsewhere obtained from a national
mortality database.
Numbers and rates for these three outcomes will be cal-
culated as the proportion of residents hospitalised (1),
number of hospital days per occupied bed per year (2) and
deaths per person-year (3). Sub-group analyses will be
conducted, by age group and gender, and by facility type.
This data will be collected from the date of randomisa-
tion to 14 months after the first visit by the GNS in the
intervention arm, and for the paired facility in the con-
trol arm. Hospitalisation records will be sought five
months after the final facility completes its intervention,
in order to allow for any delays in registering admis-
sions. Paper reports from each participating facility will
enable checking against national records.
Analyses
Analysis of primary endpoints will compare rate of ASH
admissions between treatment groups followed by other
main endpoints. Simple unadjusted rates, relative risks
and 95% confidence intervals will be obtained initially,
with subsequent multiple regression analysis adjusting
for paired randomisation and other variables. Negative
binomial regression will be used. Baseline rates will
likely be included as a covariate in regression models as
pre-intervention hospitalisation rates will be highly pre-
dictive of post-intervention rates.Sub-group analyses to check for effects that differ
from the overall treatment effect will be performed for
the following:
 facilities classed as charitable, religious or welfare
facilities vs. for “for profit” facilities
 for facilities that have only rest-home beds vs. those
with both rest-home and hospital beds
 for long-stay vs. short-term (e.g. respite or palliative
care) residents
 for facilities providing after-hours primary care
cover through either their usual GP or a contracted
after-hours primary care provider, vs. those without
such cover (effectively using ambulance and
emergency department for after-hours primary care)
All main analyses will be formally analysed on an
"intention to treat" basis. Tests of significance will be
two-tailed. Analysis of secondary outcomes will use
standard statistical procedures applicable to categorical,
continuous, or failure-time data as appropriate.
Discussion
This study is designed to provide an intervention to sup-
port clinical decisions about at-risk RAC residents and
to improve quality of care. The aim is to increase early
identification of potential health issues thus improving
resident health and reducing avoidable emergency de-
partment presentations and hospital admissions. It will
inform appropriate, cost-effective use of acute services
and will promote access to proven interventions and
practice-orientated decision making. It is intended that
this study will impact on policy and on planning and fi-
nancing models of residential aged care, and will increase
continuity of care between residential care, primary and
secondary care.
This project has potential to lead to the redesign of
systems and also to refine policies such as care practices,
staffing levels and patterns (night-staffing, after-hours
medical care and advanced nursing interventions). It is
also hoped that the study will facilitate:
 improved integration of RAC with geriatricians and
with emergency/acute services;
 clinical education for RAC staff in facilities to
increase their use of research and current guidelines;
 improved RAC palliative care practices;
 alternative residential aged care models to provide
targeted care for high risk groups, e.g.: those with
end-stage dementia
Other new models may include short RAC stays for
rehabilitation and aged care community integration. Re-
ducing hospitalisations will benefit older people residing
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risk of disability and death [26]. There is evidence that
where treatment is offered in situ, residents recover
more quickly, reducing confusion and deterioration
[14,27].
The issues that this trial addresses are not unique to
Auckland or indeed to New Zealand. Identification and
targeting of high admission facilities and refinement
of proven interventions directed toward those facil-
ities and modified individually in situ, means that the
results of this RCT are likely to be widely applicable
internationally.
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